JPML Creates Federal Docket for Oral Decongestant Cases



DOCUMENTS
  • Order


WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation created a federal docket for lawsuits alleging that makers of over-the-counter oral decongestants knew the drugs’ active ingredient, pseudoephedrine, is essentially a placebo, yet marketed them as effective.

On Dec. 6, the panel transferred the pending cases to the U.S. District Court for the Eastern District of New York and tapped Judge Brian M. Cogan to oversee the docket.

The panel agreed with the moving plaintiffs that the actions allege substantially the same wrongful conduct on the part of the named defendants, which include Procter & Gamble, McNeil Consumer Healthcare, GlaxoSmithKline …






UPCOMING CONFERENCES




HarrisMartin's Ozempic MDL Conference: Updates from the Status Hearing

March 15, 2024 - Philadelphia, PA
Kimpton Hotel Monaco Philadelphia

MORE DETAILS



HarrisMartin's MDL Conference

March 27, 2024 - Charleston, SC
The Charleston Place

MORE DETAILS